Sanpromeda - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 195,837 | 224,245 | 248,452 | 217,996 | 269,562 | 412,746 | 436,807 | 276,801 |
| Profit before tax | - | - | - | - | -5,664 | 12,887 | 18,190 | -32,443 |
| Net profit | 3,220 | 16,250 | 2,079 | 1,480 | -5,664 | 11,774 | 15,544 | -32,443 |
| Equity | 29,912 | 46,162 | 48,241 | 49,720 | 44,057 | 55,831 | 71,374 | 38,931 |
| Liabilities | 25,842 | 41,653 | 33,197 | 19,450 | 59,659 | 50,033 | 46,462 | 43,311 |
| Non-current assets | 290 | 290 | 290 | 290 | 290 | 290 | 290 | 290 |
| Current assets | 55,464 | 87,525 | 81,148 | 68,880 | 103,426 | 105,423 | 117,546 | 81,952 |
| Total assets | 55,754 | 87,815 | 81,438 | 69,170 | 103,716 | 105,713 | 117,836 | 82,242 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 92,997 | 105,623 | 75,589 |
| Social insurance contributions | - | - | - | - | - | 14,365 | 14,715 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -3.0% | +14.5% | +10.8% | -12.3% | +23.7% | +53.1% | +5.8% | -36.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.8% | 18.5% | 2.6% | 2.1% | -5.5% | 11.1% | 13.2% | -39.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 10.8% | 35.2% | 4.3% | 3.0% | -12.9% | 21.1% | 21.8% | -83.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.6% | 7.2% | 0.8% | 0.7% | -2.1% | 2.9% | 3.6% | -11.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -2.1% | 3.1% | 4.2% | -11.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 0.9 | 0.7 | 0.4 | 1.4 | 0.9 | 0.7 | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 33,572 | 46,396 | 62,113 | 54,499 | 67,391 | 103,187 | 111,524 | 92,267 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sanpromeda - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-11-18 | 2024-12-03 | 1.53 |
| 2024-10-16 | 2024-11-04 | 1.53 |
| 2024-09-17 | 2024-10-02 | 1.53 |
| 2024-08-19 | 2024-09-02 | 1.53 |
| 2024-07-16 | 2024-08-04 | 1.53 |
| 2024-06-18 | 2024-07-01 | 1.53 |
| 2024-05-16 | 2024-06-06 | 1.53 |
| 2024-04-23 | 2024-05-02 | 1.53 |
| 2024-03-27 | 2024-03-27 | 93.74 |
| 2024-03-18 | 2024-03-26 | 99.70 |
| 2024-02-19 | 2024-03-04 | 99.70 |
| 2024-01-16 | 2024-02-04 | 99.70 |
Sanpromeda - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-20 | 2026-01-20 | 0.19 |
| 2026-01-14 | 2026-01-19 | 35.99 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sanpromeda, UAB (code 300535059) is a Private Limited Liability Company engaged in wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €276.8K, down 36.6% year on year and 32.9% compared with 2023. After two profitable years, net profit turned to a loss of €32.4K in 2025, while profit margin deteriorated to -11.7% from 3.6% in 2024 and 2.9% in 2023. The 2024 results showed revenue of €436.8K and net profit of €15.5K, which marked the best performance in the three-year period. The balance sheet weakened in 2025 as total assets declined to €82.2K from €117.8K a year earlier, equity fell to €38.9K, and liabilities stood at €43.3K. The equity ratio was 47.3% and debt-to-equity was 1.11. Asset turnover reached 3.37x, indicating relatively efficient use of assets in revenue generation despite the weaker results. Revenue per employee was €92.3K, while profit per employee was -€10.8K in 2025.